# Weed is Actually ‘Rarely Justified’ to Treat Anxiety or Depression, Says Major Scientific Review > **Author:** Benjamin Caplan, MD (ABFM Board Certified, MA Lic. #240562, NPI: 1962722637) > **Publisher:** CED Clinic (https://cedclinic.com) > **Canonical URL:** https://cedclinic.com/cannabis-anxiety-use-evidence-rarely-justified-treatment/ > **Published:** 2026-03-20T19:47:17-04:00 | **Last Modified / Clinically Audited:** 2026-09-28T10:43:03-04:00 > **Clinical Summary:** Explore cannabis anxiety use evidence showing it is rarely justified for treating anxiety or depression, highlighting risks and lack of strong clinical support. --- ✦ New CED Clinical Relevance #78 Strong Clinical Relevance High-quality evidence with meaningful patient or clinical significance. Mental HealthAnxietyResearchSafety Why This Matters Clinicians need this evidence summary to counter patient requests for cannabis as an anxiety or depression treatment, since the review found insufficient evidence supporting efficacy while noting potential harms. Understanding that cannabis may worsen rather than improve psychiatric symptoms allows providers to redirect patients toward evidence-based interventions like psychotherapy and FDA-approved medications. This guidance protects vulnerable populations who might self-medicate with cannabis instead of seeking proven mental health treatments. Clinical Summary A comprehensive scientific review examining [cannabis use](https://cedclinic.com/cannabis-cardiovascular-health-insights-2024/) for anxiety and depression found insufficient evidence to support its routine clinical application for these common mental health conditions. While some patients report subjective symptom relief, the authors noted that available evidence is limited by small sample sizes, short study durations, and lack of rigorous randomized controlled trials comparing cannabis to established psychiatric treatments. The review highlighted particular concern that cannabis may paradoxically worsen anxiety or depression in some patients and carries risks of dependence and cognitive effects, especially with regular use. Current evidence suggests that cannabis treatment for mood and [anxiety disorders](https://cedclinic.com/adolescent-cannabis-use-and-anxiety-research/) is “rarely justified” compared to first-line pharmacological and psychotherapeutic interventions with robust efficacy data. Clinicians should exercise caution when patients request cannabis for depression or anxiety, as doing so may delay evidence-based treatment and expose patients to unnecessary adverse effects. Patients seeking mental health treatment should discuss cannabis use with their providers and understand that conventional therapies like antidepressants and cognitive behavioral therapy remain the standard of care with superior evidence bases for anxiety and depression. Dr. Caplan’s Take “After two decades of [clinical practice](https://cedclinic.com/cannabis-reproductive-health-women-clinical-evidence/), I can tell you that the evidence simply doesn’t support cannabis as a first-line treatment for anxiety or depression, and patients deserve to hear that clearly rather than self-medicating based on anecdote or hope. What we’re seeing in practice is that while some patients report subjective relief, the risk of dependence, cognitive effects, and symptom worsening in vulnerable populations outweighs the benefit for most people struggling with mood disorders.” Clinical Perspective While cannabis is increasingly sought by patients for anxiety and depression, a major scientific review finding insufficient evidence for mental health benefit should prompt clinicians to reconsider recommending it as a first-line option. The heterogeneity of cannabis products (varying cannabinoid ratios, delivery methods, and dosing), limited high-quality randomized controlled trials, and potential for symptom exacerbation in vulnerable populations complicate the evidence base significantly. Additionally, the retrospective nature of much existing data and publication bias toward positive findings likely overestimate true efficacy, and concurrent use with other psychotropic medications introduces potential drug interactions that are poorly characterized. Clinicians should continue to prioritize evidence-based treatments such as psychotherapy and selective serotonin reuptake inhibitors as first-line interventions, while discussing with patients that cannabis for mood or anxiety remains largely unproven and may carry individual risks including dependence, cognitive effects, 💬 Join the Conversation Have a question about how this applies to your situation? [Ask Dr. Caplan →](https://benjamincaplan.com/ask-dr-caplan) Want to discuss this topic with other patients and caregivers? [Join the forum discussion →](https://cedclinic.com/interact/discussion-forums/forum/mental-health/) Have thoughts on this? Share it: [𝕏 Share on X](https://twitter.com/intent/tweet?text=Just+read+this+on+CEDclinic.com%3A+Weed+is+actually+%27rarely+justified%27+to+treat+anxiety+or+depression%2C+says+major+scientific+review+%40drcaplan&url=https%3A%2F%2Fwww.aol.com%2Farticles%2Fweed-actually-rarely-justified-treat-175924354.html)[in Share on LinkedIn](https://www.linkedin.com/sharing/share-offsite/?url=https%3A%2F%2Fwww.aol.com%2Farticles%2Fweed-actually-rarely-justified-treat-175924354.html)[🦅 Share on BlueSky](https://bsky.app/intent/compose?text=Just+read+this%3A+Weed+is+actually+%27rarely+justified%27+to+treat+anxiety+or+depression%2C+says+major+scientific+review+--+via+%40drcaplan.bsky.social+https%3A%2F%2Fwww.aol.com%2Farticles%2Fweed-actually-rarely-justified-treat-175924354.html)[📷 Follow on Instagram](https://www.instagram.com/drbenjamincaplan/)[📝 Read more on Substack](https://substack.com/@doctorapproved)[🔔 Subscribe via RSS](https://cedclinic.com/category/cannabis-news/feed/) Related Articles - [Cannabinoids for Mental, Substance Use Disorders ‘Rarely Justified,’ Study Suggests](https://cedclinic.com/cannabinoid-clinical-trials-mental-disorders-evidence-2/) 📰 Source: [https://www.aol.com/articles/weed-actually-rarely-justified-treat-175924354.html](https://www.aol.com/articles/weed-actually-rarely-justified-treat-175924354.html) Further Reading CED Clinic BlogLandmark study finds no evidence medical cannabis treats depression, anxiety or PTSD Evidence Watch[Endocannabinoid System Research: Cannabis Anxiety Dosing](https://cedclinic.com/cannabinoid-composition-anxiety-effects-cannabis-dosing/) Evidence Watch`Endocannabinoid System Research: Athlete Mental Health` [https://cedclinic.com/contact/](https://cedclinic.com/contact/) Physician-Led, Whole-Person Care A doctor who takes the time to truly understand you. Personal care that starts with listening and is guided by experience and ingenuity. Health, Longevity, Wellness One-on-One Cannabis Guidance Metabolic Balance [Leave a Message](https://cedclinic.com/contact/) [Metabolic Care](https://cedclinic.com/metabolic/metabolic-how-it-works/) [Medical Consulting](https://cedclinic.com/book/) [Cannabis Care](https://cedclinic.com/book/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) RELATED READING AT CED CLINIC Continue exploring the evidence [Should cannabis be used for mental illnesses? – indica News](https://cedclinic.com/cannabinoid-efficacy-for-mental-health/) An in-depth discussion on the appropriateness of cannabis use for various mental illnesses, weighing current evidence and clinical perspectives. [Read More](https://cedclinic.com/cannabinoid-efficacy-for-mental-health/) [Cannabis may backfire for mental health disorders, major study finds – Fox News](https://cedclinic.com/cannabis-use-disorder-strongly-linked-to-major-depression/) A major study reveals that cannabis use might worsen [mental health disorders](https://cedclinic.com/cannabinoid-receptor-type-2-schizophrenia/), urging caution among patients and clinicians. [Learn More](https://cedclinic.com/cannabis-use-disorder-strongly-linked-to-major-depression/) [Cannabinoid Clinical Trials: Mental Health Evidence Review](https://cedclinic.com/cannabinoid-clinical-trials-mental-health-evidence-review/) A comprehensive review of [clinical trials](https://cedclinic.com/endocannabinoid-system-emotional-memory-ptsd-treatment/) assessing cannabinoids for mental health conditions, highlighting gaps and findings. [Explore Study](https://cedclinic.com/cannabinoid-clinical-trials-mental-health-evidence-review/) ### Related --- ### Verification & Medical Governance - **Lead Clinical Author:** Benjamin Caplan, MD - **Credentials:** Board Certified in Family Medicine (ABFM), Founder & CMO CED Clinic & CED Foundation, Author of *The Doctor-Approved Cannabis Handbook* (Penguin Random House). - **Clinical Scale:** 350,000+ lifetime evaluations overseen; 81,008-patient Real-World Evidence Registry (`~/.ced_rwe_vault.db`); 125,000+ peer-reviewed study literature observatory (`http://localhost:8768/api/explorer/terminal`). - **License Verification:** Commonwealth of Massachusetts License #240562 (https://checkahealthlicense.mass.gov/). - **NPI Registry:** 1962722637 (https://npiregistry.cms.hhs.gov/provider-view/1962722637). - **Ethics & Data Privacy:** Clinical registry observations adhere strictly to HIPAA Safe Harbor de-identification (45 CFR § 164.514(b)) and criteria for secondary research exemption under 45 CFR § 46.104(d)(4).